Publication|Articles|March 19, 2026
- Pharmaceutical Executive: March 2026
- Volume 46
- Issue 2
Pharmaceutical Executive: March 2026 Interactive Digital Edition
View the Pharmaceutical Executive March 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 month ago
Data and Trustabout 1 month ago
Andrew Hall: The Discipline of Convictionabout 1 month ago
Agentic AI and the Future of Commercial Excellence in Life Sciencesabout 1 month ago
Cautious Momentum: Biopharma Review and Outlookabout 1 month ago
Orphan Product Risk Contractingabout 1 month ago
JCA vs. Reality: Europe’s Push for Clinical Harmonizationabout 2 months ago
Consent‑Driven Targeting: Building Trust With Patients and HCPsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
3
Positioning A New Standard of Care in Relapsed Multiple Myeloma: Q&A with Imran Khan, MD, PhD
4
Inside Pharma's Revenue Engine: The Gross-to-Net Reckoning
5
